Related Experiment Video
Updated: Oct 3, 2026

Quantifying Pulmonary Microvascular Density in Mice Across Lobules
Published on: January 3, 2025
Association between decreased pulmonary endothelial cell thrombomodulin and local fibrin deposition in pneumonia
C M Albertson1, K K Richter, B J Kudryk
1Department of Surgery, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205, USA.
Abstract:
Thrombomodulin (TM) plays an important role in anticoagulation by forming a complex with thrombin, which subsequently activates protein C. TM is inactivated and downregulated by inflammatory cell mediators. This study examined whether bronchopneumonia is associated with changes in TM immunoreactivity, and whether a decrease in TM is accompanied by evidence of hypercoagulability, i.e. local deposition of fibrin. Double antibody staining for TM and fibrin was performed on lung tissue sections from patients who had died of pneumonia and from patients who had died rapidly, secondary to trauma. Inflammatory changes were assessed histologically and immunohistochemically using antibodies against interleukin-1alpha, tumor necrosis factor-alpha, and myeloperoxidase. Areas with bronchopneumonia exhibited markedly decreased endothelial TM staining of alveolar walls and small vessels. These changes were associated with prominent fibrin immunoreactivity. Some areas exhibited mild to moderate inflammation with little fibrin deposition and variable amounts of TM in adjacent vessels. This study is the first to relate changes of TM immunoreactivity levels to fibrin deposition in a human disease process. These data may have implications for pulmonary pathophysiology in patients with bronchopneumonia.
Insights
Bronchopneumonia significantly reduces thrombomodulin (TM) in lung tissue, leading to fibrin deposition and potential hypercoagulability. This study links decreased TM to increased clotting in pneumonia patients.
Area of Science:
- Pulmonary Medicine
- Hematology
- Immunopathology
Background:
- Thrombomodulin (TM) is crucial for anticoagulation via thrombin-activated protein C.
- Inflammatory mediators can inactivate and downregulate TM.
- Bronchopneumonia involves inflammation that may affect TM levels and coagulation.
Purpose of the Study:
- To investigate changes in TM immunoreactivity in bronchopneumonia.
- To determine if reduced TM correlates with fibrin deposition (hypercoagulability) in the lungs.
Main Methods:
- Immunohistochemistry using double antibody staining for TM and fibrin on lung tissue.
- Assessment of inflammatory markers (interleukin-1alpha, tumor necrosis factor-alpha, myeloperoxidase).
- Comparison between pneumonia patients and trauma controls.
Main Results:
- Markedly decreased endothelial TM staining in alveolar walls and small vessels in bronchopneumonia areas.
- Significant fibrin immunoreactivity observed in areas with reduced TM.
- Variable TM levels and less fibrin deposition in areas with mild inflammation.
Conclusions:
- Bronchopneumonia is associated with decreased TM immunoreactivity in lung vasculature.
- Reduced TM levels correlate with local fibrin deposition, suggesting hypercoagulability.
- Findings highlight TM's role in pulmonary pathophysiology during pneumonia.
Related Concept Videos
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Venous Thrombosis I: Introduction
Clot Retraction and Fibrinolysis
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pneumonia II: Pathophysiology
